ATE127842T1 - Megakaryocytopoietin, seine herstellung und benutzung. - Google Patents

Megakaryocytopoietin, seine herstellung und benutzung.

Info

Publication number
ATE127842T1
ATE127842T1 AT89111714T AT89111714T ATE127842T1 AT E127842 T1 ATE127842 T1 AT E127842T1 AT 89111714 T AT89111714 T AT 89111714T AT 89111714 T AT89111714 T AT 89111714T AT E127842 T1 ATE127842 T1 AT E127842T1
Authority
AT
Austria
Prior art keywords
mkp
megakaryocytopoeitin
megakaryocytopoietin
preparation
methods
Prior art date
Application number
AT89111714T
Other languages
English (en)
Inventor
Soreq Hermona
Zakut Haim
Original Assignee
Yissum Res Dev Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yissum Res Dev Co filed Critical Yissum Res Dev Co
Application granted granted Critical
Publication of ATE127842T1 publication Critical patent/ATE127842T1/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407Specifically defined cancers
    • G01N33/57426Specifically defined cancers leukemia
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475Assays involving growth factors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Endocrinology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT89111714T 1988-06-28 1989-06-27 Megakaryocytopoietin, seine herstellung und benutzung. ATE127842T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US21262388A 1988-06-28 1988-06-28

Publications (1)

Publication Number Publication Date
ATE127842T1 true ATE127842T1 (de) 1995-09-15

Family

ID=22791800

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89111714T ATE127842T1 (de) 1988-06-28 1989-06-27 Megakaryocytopoietin, seine herstellung und benutzung.

Country Status (4)

Country Link
EP (1) EP0354989B1 (de)
AT (1) ATE127842T1 (de)
DE (1) DE68924222T2 (de)
IL (1) IL90719A0 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5155211A (en) * 1986-09-17 1992-10-13 Massachusetts Institute Of Technology Megakaryocyte stimulatory factor
US5260417A (en) * 1989-04-03 1993-11-09 Genetics Institute, Inc. Megakaryocyte growth promoting activity protein
US6433142B1 (en) 1989-08-08 2002-08-13 Genetics Institute, Llc Megakaryocyte stimulating factors
US5326558A (en) * 1989-08-08 1994-07-05 Genetics Institute, Inc. Megakaryocytopoietic factor
EP0505552A4 (en) * 1990-10-12 1994-06-08 Amgen Inc Megakaryocyte maturation factors
AU2296992A (en) * 1991-06-28 1993-01-25 New England Deaconess Hospital A differentiated megakaryocyte line producing novel megakaryocyte differentiation factors
AU4190893A (en) * 1992-07-17 1994-01-20 Suntory Limited Megakaryocyte differentiation factor
CN1107891A (zh) * 1994-03-04 1995-09-06 上海贝特生物技术有限公司 人促巨核细胞生成素及其分离纯化和基因克隆方法及应用
WO1995026746A1 (en) * 1994-03-31 1995-10-12 Amgen Inc. Compositions and methods for stimulating megakaryocyte growth and differentiation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4894440A (en) * 1986-09-17 1990-01-16 Massachusetts Institute Of Technology Method of isolating megakaryocyte stimulatory factor

Also Published As

Publication number Publication date
EP0354989B1 (de) 1995-09-13
DE68924222T2 (de) 1996-02-15
EP0354989A1 (de) 1990-02-21
DE68924222D1 (de) 1995-10-19
IL90719A0 (en) 1990-01-18

Similar Documents

Publication Publication Date Title
ATE124959T1 (de) Herstellung und verwendung von nicht- glycosiliertem il-6.
DE3788289T2 (de) Rekombinanter Proteinkomplex mit Humanfaktor-VIII:C-Aktivität, seine Herstellung und Anwendung.
ES2052580T3 (es) Nuevas formas de factor-1 estimulante de colonias.
ATE78053T1 (de) Vereinfachtes verfahren zur herstellung von menschlichen lymphokinaktivierten killerzellen.
DE3580283D1 (de) Biologisch wirksame substanz mit hormonellen eigenschaften, verfahren zu ihrer herstellung und verwendung von histonen fuer medizinische zwecke.
ES2055048T3 (es) Liofilizacion de eritrocitos y medios para usarse en ella.
PT80300A (de) Herstellung von polypeptiden mit human-gammainterferonaktivitat
DE68914582D1 (de) Endothelin-DNA und ihre Verwendung.
ATE127842T1 (de) Megakaryocytopoietin, seine herstellung und benutzung.
BG60238B1 (bg) Човешки тумор- некротизиращ фактор
ATE95564T1 (de) Aeusseres membranprotein f von pseudomonas aeruginosa.
JPS5746921A (en) Oral preparation of human blood coagulation factor
CA2011992A1 (en) Use of human interferon-beta for stimulation of erythropoiesis
NO860344L (no) Vevskultur og fremstilling i permeable geler.
ATE100143T1 (de) Hormone und verfahren zur herstellung, verwendung und pruefung derselben.
DE3850933D1 (de) Anticoagulatorisches Protein PP4-X, seine Herstellung und Verwendung.
DE3783237D1 (de) Satz und methode zur bestimmung der wucherungsaktivitaet von menschlichen tumoren.
IE873143L (en) HOMOGENEOUS SHEEP TllTS AS AN INTERMEDIATE FOR THE¹PREPARATION OF HUMAN Tllts, AND THE USE THEREOF
ATE57835T1 (de) Biologisch wirksame substanz mit hormonellen eigenschaften, verfahren zu ihrer herstellung und verwendung von histonen fuer medizinische zwecke.
SU1387399A1 (ru) Питательная среда для культивирования лептоспир

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties